AT
Alterity Therapeutics Limited
ATHE · NASDAQ
$3.86 -3.98% (-$0.16)
1M -15.54%
Market Cap $91.6M
P/E Ratio -
Div. Yield -
ROE 62.23%
Bulios Fair Price
$2.41
37.6% downside
Trenutna cena
$3.86
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ATHE trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
84 /100
Cheap P/B 2.14x
EV/FFO N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 23.27%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 62.23%
ROA 49.74%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 14.52x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
28 /100
Unstable Rev. volatility 70.61%
EPS volatility 40.57%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ATHE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Stamler
Employees
11
Headquarters
Melbourne
Prihajajoči dogodki
04 MAR.
Earnings
Upcoming earnings report